Nanoform Finland Oyj NANOFS

Updated: 8 Aug 2026

NASDAQ | Biotech | Nanomedicine and drug development

No signal published yet

We already track Nanoform Finland and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Nanoform Finland free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Nanomedicine and drug development
We're already tracking Nanoform Finland Oyj — here are the latest events we've registered

Recent News

  • On August 5, 2026, Nanoform announced that it received positive scientific advice feedback from the UK MHRA regarding nanoenzalutamide. The guidance supports pursuing a UK marketing authorization application via a hybrid regulatory pathway based on existing clinical data.

What Firelda Watch includes for Nanoform Finland Oyj

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Nanoform Finland Oyj will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Vicore Pharma Holding AB (publ)
VICO
HOLD
Cereno Scientific B
CRNO B
NEUTRAL
Hansa Biopharma AB (publ)
HNSA
HOLD
BioGaia
BIOG B
HOLD
Bioarctic
BIOA B
BUY

Biotech

More companies in this sector

Want to follow Nanoform Finland Oyj? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Nanoform Finland free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Nanoform Finland Oyj NANOFS
Nanoform Finland — follow and we'll monitor it
Follow Nanoform Finland free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.